These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32339215)

  • 41. Response to recent commentaries regarding the involvement of angiotensin-converting enzyme 2 (ACE2) and renin-angiotensin system blockers in SARS-CoV-2 infections.
    Speth RC
    Drug Dev Res; 2020 Sep; 81(6):643-646. PubMed ID: 32304146
    [No Abstract]   [Full Text] [Related]  

  • 42. The Renin-Angiotensin system and SARS-CoV-2 infection: A role for the ACE2 receptor?
    Sever P; Johnston SL
    J Renin Angiotensin Aldosterone Syst; 2020; 21(2):1470320320926911. PubMed ID: 32403977
    [No Abstract]   [Full Text] [Related]  

  • 43. COVID-19 and Renin Angiotensin Blockers: Current Evidence and Recommendations.
    Messerli FH; Siontis GCM; Rexhaj E
    Circulation; 2020 Jun; 141(25):2042-2044. PubMed ID: 32282224
    [No Abstract]   [Full Text] [Related]  

  • 44. Flattening the curve of new publications on COVID-19.
    Balaphas A; Gkoufa K; Daly MJ; de Valence T
    J Epidemiol Community Health; 2020 Sep; 74(9):766-767. PubMed ID: 32631844
    [No Abstract]   [Full Text] [Related]  

  • 45. Letter to the Editor - Circulating plasma levels of angiotensin II and aldosterone in patients with coronavirus disease 2019 (COVID-19): A preliminary report.
    Henry BM; Benoit S; Lippi G; Benoit J
    Prog Cardiovasc Dis; 2020; 63(5):702-703. PubMed ID: 32659343
    [No Abstract]   [Full Text] [Related]  

  • 46. Possible Protective Effect of Renin-Angiotensin System Inhibitors in COVID-19 Induced Acute Kidney Injury.
    Kow CS; Hasan SS
    J Am Soc Nephrol; 2020 Aug; 31(8):1917-1918. PubMed ID: 32639940
    [No Abstract]   [Full Text] [Related]  

  • 47. Reply to "Coronavirus Disease 19 (COVID-19): Implications for Clinical Dental Care".
    Ather A; Patel B; Ruparel NB; Diogenes A; Hargreaves KM
    J Endod; 2020 Sep; 46(9):1342. PubMed ID: 32810475
    [No Abstract]   [Full Text] [Related]  

  • 48. Association Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19 Infection in South Korea.
    Son M; Seo J; Yang S
    Hypertension; 2020 Sep; 76(3):742-749. PubMed ID: 32654557
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Very low reporting rate of connective tissue diseases among coronavirus disease 2019 (Covid-19) patients and the renin-angiotensin system - An overlooked association?
    Giollo A; Cioffi G; Rossini M; Viapiana O; De Simone G
    Eur J Intern Med; 2020 Oct; 80():106-107. PubMed ID: 32553588
    [No Abstract]   [Full Text] [Related]  

  • 50. COVID-19, Renin-Angiotensin System, and Hematopoiesis.
    Çiftçiler R; Haznedaroğlu İC
    Turk J Haematol; 2020 Aug; 37(3):207-208. PubMed ID: 32394689
    [No Abstract]   [Full Text] [Related]  

  • 51. Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality.
    Zhou F; Liu YM; Xie J; Li H; Lei F; Yang H; Qin JJ; Cai J; Zhang XJ; Wu B; Xia M; Xiang D; Yang C; Ma X; Xu Q; Lu Z; Lu H; Xia X; Wang D; Liao X; Peng G; Yang J; Huang X; Zhang BH; Yuan Y; Wei X; Liu PP; Wang Y; Zhang P; She ZG; Xia J; Li H
    Hypertension; 2020 Aug; 76(2):e15-e17. PubMed ID: 32493070
    [No Abstract]   [Full Text] [Related]  

  • 52. Avoidable Waste of Research on Coronavirus Disease 2019 (COVID-19).
    Luo X; Lv M; Wang X; Chen Y
    Obstet Gynecol; 2020 Jul; 136(1):191. PubMed ID: 32590702
    [No Abstract]   [Full Text] [Related]  

  • 53. Coronavirus Disease 2019 and Stroke: Clinical Manifestations and Pathophysiological Insights.
    Divani AA; Andalib S; Di Napoli M; Lattanzi S; Hussain MS; Biller J; McCullough LD; Azarpazhooh MR; Seletska A; Mayer SA; Torbey M
    J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104941. PubMed ID: 32689643
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical and laboratory-derived parameters of 119 hospitalized patients with coronavirus disease 2019 in Xiangyang, Hubei Province, China.
    Shen L; Li S; Zhu Y; Zhao J; Tang X; Li H; Xing H; Lu M; Frederick C; Huang C; Wong G; Wang C; Lan J
    J Infect; 2020 Jul; 81(1):147-178. PubMed ID: 32283164
    [No Abstract]   [Full Text] [Related]  

  • 55. Inhibitors of the Renin-Angiotensin-Aldosterone System and Covid-19.
    Jarcho JA; Ingelfinger JR; Hamel MB; D'Agostino RB; Harrington DP
    N Engl J Med; 2020 Jun; 382(25):2462-2464. PubMed ID: 32356625
    [No Abstract]   [Full Text] [Related]  

  • 56. Generalizability of Coronavirus Disease 2019 (COVID-19) Clinical Prediction Models.
    Hooli S; King C
    Clin Infect Dis; 2020 Jul; 71(15):897. PubMed ID: 32271865
    [No Abstract]   [Full Text] [Related]  

  • 57. Downregulation of ACE2 induces overstimulation of the renin-angiotensin system in COVID-19: should we block the renin-angiotensin system?
    Silhol F; Sarlon G; Deharo JC; Vaïsse B
    Hypertens Res; 2020 Aug; 43(8):854-856. PubMed ID: 32439915
    [No Abstract]   [Full Text] [Related]  

  • 58. Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19.
    Reynolds HR; Adhikari S; Pulgarin C; Troxel AB; Iturrate E; Johnson SB; Hausvater A; Newman JD; Berger JS; Bangalore S; Katz SD; Fishman GI; Kunichoff D; Chen Y; Ogedegbe G; Hochman JS
    N Engl J Med; 2020 Jun; 382(25):2441-2448. PubMed ID: 32356628
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Continue ACE inhibitors / ARB'S till further evidence in coronavirus disease 2019 (COVID-19).
    Bansal S; Agstam S; Gupta A; Gupta P; Isser HS
    Indian Heart J; 2020; 72(3):212-213. PubMed ID: 32405087
    [No Abstract]   [Full Text] [Related]  

  • 60. RAAS inhibitors do not increase the risk of COVID-19.
    Fernández-Ruiz I
    Nat Rev Cardiol; 2020 Jul; 17(7):383. PubMed ID: 32444693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.